Anhui Provincial Cancer Hospital

This study is testing whether adding two new immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy helps shrink tumors before surgery in people with a specific type of breast cancer (HR+/HER2-). The goal is to see if this combination can completely eliminate…

This study is testing a combination of four existing drugs given before surgery to shrink tumors in people with triple-positive breast cancer. The goal is to see if this four-drug approach is effective and safe when used as initial treatment. Researchers will measure how well the…

This early-stage study is testing a new, highly focused type of radiation treatment called hypervision proton surgery for people with early, small lung cancer. The main goal is to see if giving one or two high doses of proton radiation is safe and can control the tumor. It will e…

This study is testing whether combining two existing drugs, TAS-102 and apatinib, can help control advanced stomach cancer when two previous standard treatments have failed. It will enroll about 30 patients to see if the combination can shrink tumors and slow the cancer's growth.…